On Thursday, Eli Lilly and Co. (NYSE: LLY) revealed topline results from the novel TOGETHER-PsA open-label Phase 3b trial evaluating the concomitant use of Taltz (ixekizumab) and Zepbound (tirzepatide ...

Eli Lilly (LLY +0.33%) is close to doing something no other pharmaceutical company has ever done: reaching $1 trillion in market value. The company briefly touched that level in November but has since ...

Marvel franchise actor Evangeline Lilly shared that she’s been dealing with the effects of a traumatic brain injury after falling months ago in Hawaii. In a video posted to Instagram, Lilly told ...

Evangeline Lilly is sharing an update on her health following an unfortunate accident in May 2025. In an Instagram video posted on Friday, Jan. 2, the 46-year-old "Lost" star shared that she has ...

Evangeline Lilly revealed that medical tests showed she suffered brain damage following a nasty fall onto a boulder that the Lost actress endured last year. In May, Lilly wrote that she “fainted at ...

Photo courtesy of Lilly Library Students examine a Torah scroll while learning about the role of manuscripts in Jewish tradition during an instructional session at the Lilly Library. Indiana ...

Its lineup and pipeline put it well ahead of even its closest competitor. The drugmaker should continue riding this wave for the foreseeable future. Furthermore, Novo Nordisk is anticipating ...

Eli Lilly and Company says the highest doses of its next-generation weight loss drug helped patients lose an average of 28.7 percent of their body weight in a new study, significantly more than its ...

A next-generation obesity shot from Eli Lilly & Co. helped patients lose almost a quarter of their body weight, potentially making the experimental drug the most potent weight-loss medicine yet. The ...